Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

1.

Prospective study on the clinical course and outcomes in transfusion-related acute lung injury*.

Looney MR, Roubinian N, Gajic O, Gropper MA, Hubmayr RD, Lowell CA, Bacchetti P, Wilson G, Koenigsberg M, Lee DC, Wu P, Grimes B, Norris PJ, Murphy EL, Gandhi MJ, Winters JL, Mair DC, Schuller RM, Hirschler NV, Rosen RS, Matthay MA, Toy P; Transfusion-Related Acute Lung Injury Study Group.

Crit Care Med. 2014 Jul;42(7):1676-87. doi: 10.1097/CCM.0000000000000323.

PMID:
24776608
2.

Risk factors and outcomes in transfusion-associated circulatory overload.

Murphy EL, Kwaan N, Looney MR, Gajic O, Hubmayr RD, Gropper MA, Koenigsberg M, Wilson G, Matthay M, Bacchetti P, Toy P; TRALI Study Group.

Am J Med. 2013 Apr;126(4):357.e29-38. doi: 10.1016/j.amjmed.2012.08.019. Epub 2013 Jan 26.

3.

Human neutrophil antibodies in a blood donor population: a lookback study.

Gottschall J, Triulzi D, Kakaiya R, Carrick D, Roback JD, Carey P, Kleinman S; NHLBI Retrovirus Epidemiology Donor Study-II.

Vox Sang. 2013 Feb;104(2):166-70. doi: 10.1111/j.1423-0410.2012.01651.x. Epub 2012 Sep 23.

4.

The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability.

Kleinman S, King MR, Busch MP, Murphy EL, Glynn SA; National Heart Lung Blood Institute Retrovirus Epidemiology Donor Study; Retrovirus Epidemiology Donor Study-II.

Transfus Med Rev. 2012 Oct;26(4):281-304, 304.e1-2. doi: 10.1016/j.tmrv.2012.04.004. Epub 2012 May 24.

5.

Plasma transfusion: current status and future directions.

Kakaiya R, Campbell-Lee S.

Transfusion. 2012 May;52 Suppl 1:1S. doi: 10.1111/j.1537-2995.2012.03625.x. No abstract available.

PMID:
22578366
6.

Population-based screening for anemia using first-time blood donors.

Mast AE, Steele WR, Johnson B, Wright DJ, Cable RG, Carey P, Gottschall JL, Kiss JE, Simon TL, Murphy EL; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II) Investigators.

Am J Hematol. 2012 May;87(5):496-502. doi: 10.1002/ajh.23171. Epub 2012 Mar 28.

7.

Genetic diversity of recently acquired and prevalent HIV, hepatitis B virus, and hepatitis C virus infections in US blood donors.

Delwart E, Slikas E, Stramer SL, Kamel H, Kessler D, Krysztof D, Tobler LH, Carrick DM, Steele W, Todd D, Wright DJ, Kleinman SH, Busch MP; NHLBI-REDS-II Study Group.

J Infect Dis. 2012 Mar 15;205(6):875-85. doi: 10.1093/infdis/jir862. Epub 2012 Jan 31.

8.

Sensitive detection assays for influenza RNA do not reveal viremia in US blood donors.

Stramer SL, Collins C, Nugent T, Wang X, Fuschino M, Heitman JW, Law J, Krysztof DE, Kiely N, Todd D, Vermeulen NM, Harrington K, Kamel H, Kelvin DJ, Busch MP, St George K, Hewlett IK, Linnen JM, Norris PJ; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II).

J Infect Dis. 2012 Mar 15;205(6):886-94. doi: 10.1093/infdis/jir863. Epub 2012 Jan 31.

9.

Iron deficiency in blood donors: the REDS-II Donor Iron Status Evaluation (RISE) study.

Cable RG, Glynn SA, Kiss JE, Mast AE, Steele WR, Murphy EL, Wright DJ, Sacher RA, Gottschall JL, Tobler LH, Simon TL; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II).

Transfusion. 2012 Apr;52(4):702-11. doi: 10.1111/j.1537-2995.2011.03401.x. Epub 2011 Oct 24.

10.

The difference between fingerstick and venous hemoglobin and hematocrit varies by sex and iron stores.

Cable RG, Steele WR, Melmed RS, Johnson B, Mast AE, Carey PM, Kiss JE, Kleinman SH, Wright DJ; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II).

Transfusion. 2012 May;52(5):1031-40. doi: 10.1111/j.1537-2995.2011.03389.x. Epub 2011 Oct 20.

11.

Demographics of successful, unsuccessful and deferral visits at six blood centers over a 4-year period.

Custer B, Schlumpf K, Simon TL, Spencer BR, Wright DJ, Wilkinson SL; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II).

Transfusion. 2012 Apr;52(4):712-21. doi: 10.1111/j.1537-2995.2011.03353.x. Epub 2011 Sep 26.

12.

Adverse reactions and other factors that impact subsequent blood donation visits.

Custer B, Rios JA, Schlumpf K, Kakaiya RM, Gottschall JL, Wright DJ; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II).

Transfusion. 2012 Jan;52(1):118-26. doi: 10.1111/j.1537-2995.2011.03216.x. Epub 2011 Jun 17.

13.

Donation frequency of blood donors participating in a prospective cohort study of iron status.

Bahrami SH, Guiltinan AM, Schlumpf KS, Scott E, Banks LL, D'Andrea P, Hartman EL, Vij V, Wright DJ, Spencer B, Murphy EL; NHLBI Retrovirus Epidemiology Donor Study-II.

Transfusion. 2011 Jun;51(6):1207-12. doi: 10.1111/j.1537-2995.2010.03002.x. Epub 2011 Jan 7.

14.

Deconstructing the risk for malaria in United States donors deferred for travel to Mexico.

Spencer B, Kleinman S, Custer B, Cable R, Wilkinson SL, Steele W, High PM, Wright D; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II).

Transfusion. 2011 Nov;51(11):2398-410. doi: 10.1111/j.1537-2995.2011.03158.x. Epub 2011 May 12.

15.

The Leukocyte Antibody Prevalence Study-II (LAPS-II): a retrospective cohort study of transfusion-related acute lung injury in recipients of high-plasma-volume human leukocyte antigen antibody-positive or -negative components.

Kleinman SH, Triulzi DJ, Murphy EL, Carey PM, Gottschall JL, Roback JD, Carrick D, Mathew S, Wright DJ, Cable R, Ness P, Gajic O, Hubmayr RD, Looney MR, Kakaiya RM; National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study-II.

Transfusion. 2011 Oct;51(10):2078-91. doi: 10.1111/j.1537-2995.2011.03120.x. Epub 2011 Mar 29.

16.

Establishing assay cutoffs for HLA antibody screening of apheresis donors.

Carrick DM, Norris PJ, Endres RO, Pandey S, Kleinman SH, Wright D, Sun Y, Busch MP; National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study-II.

Transfusion. 2011 Oct;51(10):2092-101. doi: 10.1111/j.1537-2995.2010.03048.x. Epub 2011 Feb 18.

17.

False-positive nucleic acid test results for human immunodeficiency virus RNA and hepatitis C virus RNA: an underappreciated problem.

Kakaiya R, Gordon S, Zimmerman A, Verlinsky R, Ahmed S, Phillips M.

Transfusion. 2011 Jan;51(1):225-6. doi: 10.1111/j.1537-2995.2010.02884.x. No abstract available.

PMID:
21219326
18.

Absence of hemolytic disease of fetus and newborn despite maternal high-titer IgG anti-Ku.

Kakaiya RM, Whaley A, Howard-Menk C, Rami J, Papari M, Campbell-Lee S, Malecki Z.

Immunohematology. 2010;26(3):119-23.

PMID:
21214298
19.

Blood donations from previously transfused or pregnant donors: a multicenter study to determine the frequency of alloexposure.

Rios JA, Schlumpf KS, Kakaiya RM, Triulzi DJ, Roback JD, Kleinman SH, Murphy EL, Gottschall JL, Carey PM; NHLBI Retrovirus Epidemiology Donor Study-II.

Transfusion. 2011 Jun;51(6):1197-206. doi: 10.1111/j.1537-2995.2010.02991.x. Epub 2010 Dec 23.

20.

The influence of donor antibody strength and recipient antigens on transfusion-related acute lung injury development.

Kakaiya R.

Transfusion. 2010 Dec;50(12):2533-5. doi: 10.1111/j.1537-2995.2010.02933.x. No abstract available.

PMID:
21126250
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk